You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GILD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GILD ($61.69) is undervalued by 5.75% relative to our estimate of its Fair Value price of $65.45 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GILD ($61.69) is not significantly undervalued (5.75%) relative to our estimate of its Fair Value price of $65.45 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
What is the 52 week high and low for Gilead Sciences (NASDAQ: GILD)?
(NASDAQ: GILD) Gilead Sciences's 52-week high was $74.12, and its 52-week low was $57.17. It is currently -16.77% from its 52-week high and 7.92% from its 52-week low.
How much is Gilead Sciences stock worth today?
(NASDAQ: GILD) Gilead Sciences currently has 1,253,367,394 outstanding shares. With Gilead Sciences stock trading at $61.69 per share, the total value of Gilead Sciences stock (market capitalization) is $77.32B.
Gilead Sciences stock was originally listed at a price of $1.20 in Dec 31, 1997. If you had invested in Gilead Sciences stock at $1.20, your return over the last 24 years would have been 5,062.34%, for an annualized return of 17.86% (not including any dividends or dividend reinvestments).
How much is Gilead Sciences's stock price per share?
(NASDAQ: GILD) Gilead Sciences stock price per share is $61.69 today (as of Sep 30, 2022).
What is Gilead Sciences's Market Cap?
(NASDAQ: GILD) Gilead Sciences's market cap is $77.32B, as of Oct 2, 2022.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Gilead Sciences's market cap is calculated by multiplying GILD's current stock price of $61.69 by GILD's total outstanding shares of 1,253,367,394.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.